Tumor-associated epilepsy at diagnosis in glioblastoma patients reveals an inflammatory molecular signature and is associated with better overall survival
- 19 June 2026
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 28 (10) , 2461-2471
Abstract
Background: Glioblastoma (GB) is the most aggressive primary brain tumor in adults. Tumor-associated epilepsy (TAE) at diagnosis is common, yet its prognostic significance remains unclear. Methods: We analyzed a retrospective multicenter test cohort of 855 GB patients (Aachen, Hamburg, Bielefeld) and validated findings in a prospectively collected cohort of 344 patients (Erlangen). Survival was assessed using multivariable Cox regression, propensity score matching, and interaction modeling of TAE and extent of resection (EOR). Molecular profiling included methylation-based classification, epigenetic deconvolution, and spatial transcriptomics. Results: Tumor-associated epilepsy was independently associated with improved survival (hazard ratio [HR] 0.81, 95% CI 0.69-0.99, P = .036, absolute survival advantage ∼4-5 months). This effect was validated in the independent cohort (C-index 0.68, 95% CI 0.62–0.74) and persisted in propensity-matched analyses (HR 0.74, 95% CI 0.56-0.96, P = .027). Interaction modeling revealed that gross total resection (GTR) improved survival in both groups but particularly in patients with TAE (EOR interaction HR 0.69, 95% CI 0.49-0.99, P = .041). In this subgroup, partial resection provided no significant advantage over biopsy, whereas patients without seizures benefited incrementally from both partial resection and GTR. Molecular analysis demonstrated enrichment of the RTK II subtype, differentiated cell states, and an inflammatory microenvironment in GB with TAE; tumors without seizures displayed neuronal and stem-like features. Functional validation using electrogenomics showed that GB cortical slices with increased inflammatory score exhibited synchronization of action potentials characteristic for seizure-like epileptiform activity. Conclusions: Tumor-associated epilepsy at diagnosis is a favorable prognostic marker in GB, defining a biologically distinct subgroup. Seizure status modifies the prognostic effect of surgical resection, underscoring the importance of GTR particularly in patients presenting with TAE.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (DE 3318/4-1 to D. Delev, HE 8145/5-1, HE 8145/5-2 to D.H.H)
This publication has 24 references indexed in Scilit:
- Epilepsy as primary tumor manifestation correlates with patient status, age, and tumor volume but not with survival in elderly glioblastoma patients: a retrospective bicentric analysisNeurosurgical Review, 2025
- Human organotypic brain slice cultures: a detailed and improved protocol for preparation and long-term maintenanceJournal of Neuroscience Methods, 2024
- Glioblastoma hijacks neuronal mechanisms for brain invasionCell, 2022
- Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastomaCancer Cell, 2022
- Disconnecting multicellular networks in brain tumoursNature Reviews Cancer, 2022
- T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10Nature Communications, 2022
- Glutamatergic synaptic input to glioma cells drives brain tumour progressionNature, 2019
- Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and diseaseNature Communications, 2018
- DNA methylation-based classification of central nervous system tumoursNature, 2018
- Brain tumour cells interconnect to a functional and resistant networkNature, 2015